期刊文献+

百日咳杆菌腺苷酸环化酶毒素基因的克隆及原核表达

Cloning and Prokaryotic Expression of Bordetella pertussis Adenylate Cyclase Toxin Gene
原文传递
导出
摘要 目的克隆百日咳杆菌腺苷酸环化酶毒素(CyaA,ACT)基因,表达并纯化重组CyaA蛋白。方法从百日咳杆菌CS株的基因组DNA中PCR扩增CyaA编码基因,克隆入载体pET30a,构建重组原核表达质粒pET30a/cyaA,转化感受态大肠杆菌BL21(DE3),IPTG诱导表达。表达的重组蛋白经8mol/L尿素变性、透析复性、DEAE阴离子交换柱纯化后,采用Western blot法鉴定其反应原性。结果重组原核表达质粒pET30a/cyaA经PCR、双酶切及测序证明构建正确;表达的重组蛋白主要以包涵体形式存在,表达量约占菌体总蛋白的20%;纯化的重组蛋白纯度达90%左右,可与全细胞百日咳疫苗和无细胞百日咳疫苗免疫血清结合。结论已成功克隆了百日咳杆菌cyaA基因,并在大肠杆菌中表达了重组CyaA蛋白,为进一步开展CyaA的应用研究奠定了基础。 Objective To clone Bordetella pertussis adenylate cyclase toxin(CyaA,ACT)gene,and express and purify recombinant CyaA protein.Methods The gene encoding CyaA was amplified from genomic DNA of B.pertussis CS strain by PCR and cloned into vector pET30a.The constructed recombinant plasmid pET30a /cyaA was transformed to competent E.coli BL21(DE3) for expression under induction of IPTG.The expressed recombinant protein was de-naturalized with 8 mol /L urea,re-naturalized by dialysis,purified by DEAE anion exchange chromatography and identified for reactogenicity by Western blot.Results PCR,restriction analysis and sequencing proved that recombinant plasmid pET30a /cyaA was constructed correctly.The expressed recombinant protein mainly existed in a form of inclusion body,contained about 20% of total somatic protein,reached a purity of about 90% after purification and showed specific reactions with sera of mice immunized with whole cell and acellular pertussis vaccines.Conclusion B.pertussis cyaA gene was successfully cloned,and recombinant CyaA protein was expressed in E.coli,which laid a foundation of study on application of CyaA.
出处 《中国生物制品学杂志》 CAS CSCD 2010年第1期9-12,共4页 Chinese Journal of Biologicals
关键词 百日咳杆菌 腺苷酸环化酶毒素基因 克隆 表达 Bordetella pertussis Adenylate cyclase toxin(CyaA, ACT)gene Cloning Expression
  • 相关文献

参考文献8

  • 1Cherry JD, Xing DX, Newland P, et al. Determination of serum antibody to Bordetella pertussis adenylate cyelase toxin in vaccinated and unvaccinated children and in children and adults with pertussis. Clin Infect Dis, 2004, 38 (4): 502-507.
  • 2Orr B, Douce G, Baillie S, et al. Adjuvant effects of adenylate cyclase toxin of Bordetella pertussis after intranasal immunisation of mice. Vaccine, 2007, 25 ( 1 ): 64-71.
  • 3Berraondo P, Nouze C, Preville X, et al. Eradication of large tumors in mice by a tritherapy targeting the innate, adaptive, and regulatrry components of the immune system. Cancer Res, 2007, 67 (18): 8847-8855.
  • 4Loucka J, Schlecht G. Vodol,4nowi J, et al. Delivery of a MalE CD4 (+)-T-cell epitope into the major histocompatibility complex class II antigen presentation pathway by Bordetella pertussis adenylate cyclase. Infect Immun, 2002, 70 (2): 1002-1005.
  • 5萨姆布鲁克J,拉塞尔DW.分子克隆实验指南(下册).黄培堂,等.译.3版.北京:科学出版社,2002:1723-1726.
  • 6Fayolle C, Bauche C, Ladant D, et al. Bordetella pertussis adenylate cyclase delivers chemically coupled CD8+ T-cell epitopes to dendritic cells and elicits CTL in vivo. Vaccine, 2004, 23 (5): 604-614.
  • 7Fiser R, Masin J, Basler M, et al. Third activity of Bordetella adenylate cyclase (AC) toxin-hemolysin. Membrane translocation of AC domain polypeptide promotes calcium influx into CDIIb + monocytes independently of the catalytic and bemolytic activities. J Bio Chem, 2007, 282 (5): 2808-2820.
  • 8Cheung GY, Xing D, Prior S, et al. Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model,Infect Immun, 2006, 74 (12): 6797-6805.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部